
Dis‑Chem's FY2026 Mixed as Revenue Climbs, Earnings Dip
Loading player...
Dis‑Chem CEO Rui Morais unpacks a results set showing strong revenue growth but pressure on headline earnings. He explains the Group’s R445m investment into its healthcare ecosystem, the performance of Better Rewards, margin pressure in dispensary and wholesale, and how the Store of the Future will reshape customer experience and profitability.

